ArticlebioRxiv : the preprint server for biology2026
Inferring structure factors of weakly populated excited states in perturbative crystallography experiments.
Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Perturbative X-ray crystallography can visualize functional dynamics and conformational changes in proteins at atomic resolution. During a typical perturbative crystallography experiment, only a fraction of protein molecules in a crystal will be perturbed, or "excited". As a result, the observed data represent a mixture of excited and ground states. The conventional approach to estimating the excited-state structure factor amplitudes is to linearly extrapolate the difference between the structure factor amplitudes of the perturbed and unperturbed data. This approach often fails to yield well-refined structural models because it amplifies experimental errors and neglects phase differences between the ground and excited states. Here, we introduce an approach to estimating excited-state structure factor amplitudes that starts from a statistical prior for the correlations between excited and ground states. Using benchmarks from time-resolved crystallography and a drug-fragment screen, we illustrate how this approach effectively addresses the limitations of traditional extrapolation.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.